Vertex Pharmaceuticals, Inc. (VRTX)
496.38
-2.04
(-0.41%)
USD |
NASDAQ |
Jul 09, 16:00
495.85
-0.54
(-0.11%)
After-Hours: 16:35
Vertex Pharmaceuticals Total Return Price : 496.38 for July 9, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| July 08, 2026 | 498.43 |
| July 07, 2026 | 522.25 |
| July 06, 2026 | 529.59 |
| July 02, 2026 | 528.04 |
| July 01, 2026 | 498.01 |
| June 30, 2026 | 496.73 |
| June 29, 2026 | 499.65 |
| June 26, 2026 | 491.34 |
| June 25, 2026 | 480.18 |
| June 24, 2026 | 475.20 |
| June 23, 2026 | 468.42 |
| June 22, 2026 | 466.79 |
| June 18, 2026 | 451.63 |
| June 17, 2026 | 458.99 |
| June 16, 2026 | 453.17 |
| June 15, 2026 | 450.46 |
| June 12, 2026 | 444.92 |
| June 11, 2026 | 445.04 |
| June 10, 2026 | 435.71 |
| June 09, 2026 | 445.77 |
| June 08, 2026 | 442.96 |
| June 05, 2026 | 446.83 |
| June 04, 2026 | 441.74 |
| June 03, 2026 | 428.34 |
| June 02, 2026 | 425.09 |
| Date | Value |
|---|---|
| June 01, 2026 | 438.40 |
| May 29, 2026 | 447.54 |
| May 28, 2026 | 447.97 |
| May 27, 2026 | 437.22 |
| May 26, 2026 | 435.93 |
| May 22, 2026 | 434.52 |
| May 21, 2026 | 433.54 |
| May 20, 2026 | 430.44 |
| May 19, 2026 | 434.31 |
| May 18, 2026 | 436.58 |
| May 15, 2026 | 436.95 |
| May 14, 2026 | 450.41 |
| May 13, 2026 | 453.06 |
| May 12, 2026 | 448.29 |
| May 11, 2026 | 435.17 |
| May 08, 2026 | 429.82 |
| May 07, 2026 | 425.00 |
| May 06, 2026 | 427.65 |
| May 05, 2026 | 424.36 |
| May 04, 2026 | 429.85 |
| May 01, 2026 | 423.92 |
| April 30, 2026 | 427.38 |
| April 29, 2026 | 423.24 |
| April 28, 2026 | 430.14 |
| April 27, 2026 | 426.01 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| CRISPR Therapeutics AG | 56.30 |
| Halozyme Therapeutics, Inc. | 78.64 |
| Alnylam Pharmaceuticals, Inc. | 312.77 |
| Biogen, Inc. | 198.67 |
| Gilead Sciences, Inc. | 134.78 |